Kainulainen Markus H, Nichol Stuart T, Albariño César G, Spiropoulou Christina F
Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia.
J Infect Dis. 2017 Dec 12;216(11):1380-1385. doi: 10.1093/infdis/jix486.
Modern ebolavirus diagnostics rely primarily on quantitative reverse transcription-polymerase chain reaction (qRT-PCR), a sensitive method to detect viral genetic material in the acute phase of the disease. However, qRT-PCR does not confirm presence of infectious virus, presenting limitations in patient and outbreak management. Attempts to isolate infectious virus rely on in vivo or basic cell culture approaches, which prohibit rapid results and screening. In this study, we present a novel reporter cell line capable of detecting live ebolaviruses. These cells permit sensitive, large-scale screening and titration of infectious virus in experimental and clinical samples, independent of ebolavirus species and variant.
现代埃博拉病毒诊断主要依赖定量逆转录聚合酶链反应(qRT-PCR),这是一种在疾病急性期检测病毒遗传物质的灵敏方法。然而,qRT-PCR无法确认传染性病毒的存在,在患者和疫情管理方面存在局限性。分离传染性病毒的尝试依赖于体内或基础细胞培养方法,这些方法无法快速得出结果和进行筛查。在本研究中,我们展示了一种能够检测活埃博拉病毒的新型报告细胞系。这些细胞能够对实验和临床样本中的传染性病毒进行灵敏、大规模的筛查和滴定,且不受埃博拉病毒种类和变体的影响。